Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment

Updates in Surgery
Annamaria AgnesDomenico D'Ugo

Abstract

Gastric cancer (GC) is the fifth malignancy and the third cause of cancer death worldwide, according to the global cancer statistics presented in 2018. Its definition and staging have been revised in the eight edition of the AJCC/TNM classification, which took effect in 2018. Novel molecular classifications for GC have been recently established and the process of translating these classifications into clinical practice is ongoing. The cornerstone of GC treatment is surgical, in a context of multimodal therapy. Surgical treatment is being standardized, and is evolving according to new anatomical concepts and to the recent technological developments. This is leading to a massive improvement in the use of mini-invasive techniques. Mini-invasive techniques aim to be equivalent to open surgery from an oncologic point of view, with better short-term outcomes. The persecution of better short-term outcomes also includes the optimization of the perioperative management, which is being implemented on large scale according to the enhanced recovery after surgery principles. In the era of precision medicine, multimodal treatment is also evolving. The long-time-awaited results of many trials investigating the role for preoperative and postop...Continue Reading

References

May 1, 1991·British Journal of Cancer·D PalliE Valdes
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T SautnerR Jakesz
Aug 14, 2002·Journal of Surgical Oncology·Vitali SkoropadVasili Zagrebin
Jul 1, 2008·Japanese Journal of Clinical Oncology·Yukinori KurokawaUNKNOWN Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group
Aug 2, 2008·The New England Journal of Medicine·Mitsuru SasakoUNKNOWN Japan Clinical Oncology Group
Nov 20, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·W HohenbergerS Merkel
May 13, 2009·Annals of Surgical Oncology·Chan-Young Kim, Doo-Hyun Yang
Jun 18, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hongyu WuSusan S Devesa
May 12, 2011·The British Journal of Surgery·D MarrelliUNKNOWN Italian Research Group for Gastric Cancer
Aug 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharven TaghaviAlliric I Willis
Dec 18, 2012·Japanese Journal of Clinical Oncology·Shinichi HasegawaMunetaka Masuda
Oct 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T WaddellUNKNOWN European Society of Radiotherapy and Oncology (ESTRO)
Nov 19, 2013·Annals of Surgical Oncology·David D SmithRoderich E Schwarz
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 27, 2016·World Journal of Gastroenterology : WJG·Taeil Son, Woo Jin Hyung
Feb 21, 2016·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Leonie HaverkampRichard van Hillegersberg
Feb 22, 2016·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Takeshi SanoYasuo Ohashi
Feb 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yanfeng HuGuoxin Li
Jun 10, 2016·Annals of Surgery·Takeshi SanoUNKNOWN Stomach Cancer Study Group of the Japan Clinical Oncology Group
Jun 28, 2016·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·UNKNOWN Japanese Gastric Cancer Association
Jun 28, 2016·Human Pathology·Raul S GonzalezChrista L Whitney-Miller
Oct 21, 2016·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Koichi SudaIchiro Uyama
Aug 24, 2016·The British Journal of Surgery·E J JongeriusS S Gisbertz
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E C SmythUNKNOWN ESMO Guidelines Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Helicobacter
Ceu FigueiredoJose Carlos Machado
World Journal of Gastroenterology : WJG
Mihaela Chivu-EconomescuCarmen C Diaconu
Current Oncology Reports
Fabian M Johnston, Michael Beckman
Critical Reviews in Oncology/hematology
M A GuicciardiE Croce
© 2021 Meta ULC. All rights reserved